drugset / Trial / NCT00746811

Effects of Prescription Omega-3 on LDL-C in Primary Hypercholesterolemia

NCT00746811

RandomizedCrossoverDouble-blindTreatment

Summary

The objectives of this study are to assess the effects of 4 g/d P-OM3, compared with placebo, on LDL-C and other aspects of the fasting lipid profile in subjects with primary hypercholesterolemia.

Timeline

Start
2010-01
Primary completion
2010-07
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Lovaza Other / unclassified 4 g

Indications